- UroToday Home
- Urologic Oncology
Prostate Cancer Abstracts and Beyond
Recent Abstracts
-
A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer.Prostate CancerAugust 23, 2019
-
Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort.Prostate CancerAugust 23, 2019
-
Assessing a Patient's Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood.Prostate CancerAugust 23, 2019
-
Diagnostic Impacts of Clinical Laboratory-Based [-2] proPSA Indices on Any Grade, Gleason Grade Group ≥2 or ≥3 of Prostate Cancer in the PSA Below 10 ng/mL.Prostate CancerAugust 23, 2019
-
Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level.Prostate CancerAugust 23, 2019
-
Sequencing strategies in the new treatment landscape of prostate cancer.Prostate CancerAugust 22, 2019
-
Sexual function recovery after robot-assisted radical prostatectomy: Outcomes from an Italian referral centre and predicting nomogram.Prostate CancerAugust 22, 2019
-
A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging.Prostate CancerAugust 22, 2019
-
Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review.Prostate CancerAugust 22, 2019
-
Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.Prostate CancerAugust 22, 2019
Beyond the Abstracts
-
The Adoption and Assessment of Active Surveillance in Community Urology Practices - Beyond the AbstractProstate CancerAugust 22, 2019
-
Improving Ultrasound-based Prostate Volume Estimation - Beyond the AbstractProstate CancerAugust 8, 2019
-
Oligometastases in Prostate Cancer: Ablative Treatment - Beyond the AbstractProstate CancerJuly 28, 2019
-
Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer - Beyond the AbstractProstate CancerJuly 28, 2019
-
National Survey of Patterns Employing Targeted MRI/US Guided Prostate Biopsy in the Diagnosis and Staging of Prostate Cancer - Beyond the AbstractProstate CancerJuly 15, 2019
-
Outcomes of Serial Multiparametric Magnetic Resonance Imaging and Subsequent Biopsy in Men with Low-risk Prostate Cancer Managed with Active Surveillance - Beyond the AbstractProstate CancerJuly 1, 2019
-
High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility - Beyond the AbstractProstate CancerJuly 1, 2019
-
Randomized Phase II Trial of Neoadjuvant Everolimus in Patients with High-risk Localized Prostate Cancer - Beyond the AbstractProstate CancerJune 26, 2019
-
Circulating miRNAs as Non-invasive Biomarkers to Predict Aggressive Prostate Cancer After Radical Prostatectomy - Beyond the AbstractProstate CancerJune 21, 2019
-
Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 years of Age - Beyond the AbstractProstate CancerJune 21, 2019
E-Newsletters
Free Daily and Weekly newsletters offered by content of interest
The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
